文献速递创伤与烧伤复苏、休克与脓毒症

复苏性主动脉球囊阻断术治疗骨盆钝性创伤与危及生命出血:一级创伤中心20年经验

Resuscitative endovascular balloon occlusion of the aorta for pelvic blunt trauma and life-threatening hemorrhage: A 20-year experience in a Level I trauma center.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论在严重骨盆创伤伴极端失血性休克患者中,REBOA(3区球囊充盈)可显著改善收缩压,作者支持其作为确定性止血前的桥接治疗。

该研究为法国一级创伤中心1996—2017年的回顾性研究,纳入所有连续接受REBOA的32例患者,指征为极端血流动力学不稳定(入院收缩压<60 mmHg、创伤复苏室初始复苏后收缩压<90 mmHg或创伤后心脏骤停)且骨盆X线阳性。球囊充盈后收缩压从60(35-73)mmHg显著升至115(91-128)mmHg(p<0.001)。血管并发症发生率为19%(5例),无截肢,11例启动肾脏替代治疗,15例发生严重横纹肌溶解。作者结论认为REBOA在严重骨盆创伤和危及生命出血后改善血流动力学方面安全有效,支持其作为确定性止血治疗的桥接。

要点

  • 指征为极端血流动力学不稳定(入院收缩压<60 mmHg、初始复苏后收缩压<90 mmHg或创伤后心脏骤停)且骨盆X线阳性。
  • 32例患者中球囊充盈后收缩压从60(35-73)mmHg升至115(91-128)mmHg(p<0.001)。
  • 血管并发症发生率为19%(5例),无截肢;11例启动肾脏替代治疗,15例发生严重横纹肌溶解。
  • 32例中2例技术失败、1例球囊未充盈,19例第28天未存活。
  • 作者支持将REBOA作为严重骨盆创伤后确定性止血治疗的桥接。

适用人群与场景

  • 法国一级创伤中心1996至2017年连续纳入的疑似严重骨盆创伤伴极端失血性休克患者。
  • REBOA指征为极端血流动力学不稳定(入院收缩压<60 mmHg、创伤复苏室初始复苏后收缩压<90 mmHg或创伤后心脏骤停)且骨盆X线阳性。

诊断标准与关键阈值

  • REBOA指征包括:(1)极端血流动力学不稳定:入院收缩压<60 mmHg、创伤复苏室初始复苏后收缩压<90 mmHg或创伤后心脏骤停;(2)骨盆X线阳性。

处置流程与药物剂量

  • 在3区(肾动脉下至主动脉分叉)充盈球囊以阻断严重骨盆创伤后持续出血。
  • REBOA作为确定性止血治疗的桥接。

红旗征与不能漏的情况

  • 极端血流动力学不稳定:入院收缩压<60 mmHg、初始复苏后收缩压<90 mmHg或创伤后心脏骤停。

研究设计与关键结果

  • 研究类型为回顾性研究,纳入32例接受REBOA的患者,仅2例技术失败、1例球囊未充盈,19例第28天未存活。
  • 球囊充盈后收缩压从60(35-73)mmHg升至115(91-128)mmHg(p<0.001)。
  • 血管并发症发生率为19%(5例),无截肢;11例启动肾脏替代治疗,15例发生严重横纹肌溶解。

证据类型、等级与局限

  • 证据类型为回顾性研究,证据等级为治疗性研究IV级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为REBOA在严重骨盆创伤和危及生命出血后改善血流动力学方面安全有效,支持其作为确定性止血治疗的桥接。
  • 适用人群为疑似严重骨盆创伤伴极端失血性休克且骨盆X线阳性的患者;血管并发症发生率为19%(5例),11例启动肾脏替代治疗,15例发生严重横纹肌溶解。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used as a noninvasive clamp of the aorta after diverse posttraumatic injuries. Balloon inflation in zone 3 (from the lower renal artery to the aortic bifurcation) can be performed to stop ongoing bleeding after severe pelvic trauma with life-threatening hemorrhage. The aim of our study was to describe our 20-year experience with REBOA in terms of efficacy and safety in patients with a suspicion of severe pelvic trauma and extreme hemorrhagic shock.

METHODS: We performed a retrospective study from 1996 to 2017 in a French Level I trauma center. All consecutive patients who underwent a REBOA procedure were included. REBOA indication relied on (1) extreme hemodynamic instability (systolic arterial blood pressure [SBP] < 60 mm Hg on admission, SBP < 90 mm Hg despite initial resuscitation in the trauma bay or posttraumatic cardiac arrest) and (2) positive pelvic X-ray. Efficacy endpoints were vital signs and coagulation parameters before and after balloon inflation. Safety endpoints were REBOA-related complications: vascular events, acute renal failure, and rhabdomyolysis.

RESULTS: Within the study period, 32 patients underwent a REBOA procedure. Only two patients had technical failure and balloon was not inflated in one patient. Nineteen patients did not survive at day 28. The REBOA significantly improved SBP from 60 (35-73) mm Hg to 115 (91-128) mm Hg (p < 0.001). We also reported a high rate of vascular complications (19%, n = 5 patients) but no amputation. Renal replacement therapy was initiated in 11 patients, and 15 patients had severe rhabdomyolysis.

CONCLUSION: The REBOA is safe and effective in improving hemodynamics after severe pelvic trauma and life-threatening hemorrhage. Our study supports the use of REBOA as a bridge to definitive hemostatic treatment after severe pelvic trauma.

LEVEL OF EVIDENCE: Therapeutic, level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Pieper A, Thony F, Brun J, et al. Resuscitative endovascular balloon occlusion of the aorta for pelvic blunt trauma and life-threatening hemorrhage: A 20-year experience in a Level I trauma center. J Trauma Acute Care Surg. 2018. PMID: 29298239. doi:10.1097/TA.0000000000001794

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。